Management of bleeding in the cirrhotic patient

Journal of Gastroenterology and Hepatology (Australia)

Volumn 17, Issue 4, 2002, Pages 355-360

  Chung, Sydney ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cirrhosis; Cost effectiveness; Endoscopic band ligation; Endoscopic sclerotherapy; Esophageal banding; Esophageal varices; Gastric varices; Gastrointestinal bleeding; Multidisciplinary approach; Somatostatin analogs

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYANOACRYLATE; GLYCERYL TRINITRATE; OCTREOTIDE; SCLEROSING AGENT; SOMATOSTATIN DERIVATIVE; TERLIPRESSIN; UNCLASSIFIED DRUG; VALPREOTIDE; VASOPRESSIN;

ALGORITHM; ASPIRATION; CLINICAL TRIAL; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; ENDOSCOPIC SURGERY; ESOPHAGUS VARICES; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; HUMAN; INTERMETHOD COMPARISON; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; META ANALYSIS; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RISK FACTOR; SCLEROTHERAPY; SIDE EFFECT; STOMACH VARICES; TREATMENT OUTCOME; VEIN LIGATION; VEIN OCCLUSION;

EID: 0036091716     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2002.02723.x     Document Type: Conference Paper

References (59)

1. The national ASGE survey on upper gastrointestinal bleeding II clinical prognostic factors
2. Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: A meta-analysis
3. Liver function and pharmacological considerations in pathogenesis and treatment of portal hypertension
4. The treatment of portal hypertension: A meta-analytic review
5. Effects of somatostatin on hepatic and systemic hemodynamics in patients with cirrhosis of the liver: Comparison with vasopressin
6. A prospective randomised controlled trial comparing the efficacy of somatostatin with injection sclerotherapy in the control of bleeding oesophageal varices
7. A prospective randomized trial comparing somatostatin and sclerotherapy in the treatment of acute variceal bleeding
8. Somatostatin and urgent sclerotherapy in active oesophageal variceal bleeding
9. Randomized controlled trial of sclerotherapy versus somatostatin infusion in the prevention of early rebleeding following acute variceal hemorrhage in patients with cirrhosis
10. Octreotide infusion or emergency sclerotherapy for variceal hemorrhage
11. A multicentre randomised trial comparing octreotide and injection sclerotherapy in the management and outcome of acute variceal haemorrhage
12. Efficacy of octreotide and sclerotherapy in the treatment of acute variceal bleeding in cirrhotic patients. A prospective, multicenter and randomized clinical trial
13. Early administration of somatostatin and efficacy of sclerotherapy in acute oesophageal variceal bleeds: The European Acute Bleeding Oesophageal Variceal Episodes (ABOVE) randomised trial
14. Somatostatin alone or combined with emergency sclerotherapy in the treatment of acute esophageal variceal bleeding: A prospective randomized trial
15. Sclerotherapy with or without octreotide for acute variceal bleeding
16. Comparison of endoscopic variceal sclerotherapy alone and in combination with octreotide in controlling acute variceal hemorrhage and early rebleeding in patients with low-risk cirrhosis
17. Octreotide compared with placebo in a treatment strategy for early rebleeding in cirrhosis. A double blind, randomized pragmatic trial
18. Early administration of terlipressin plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients
19. Early administration of vapreotide in variceal bleeding in patients with cirrhosis. French Club for the Study of Portal Hypertension
20. Prospective ran-domised study of effect of octreotide on rebleeding from oesophageal varices after endoscopic banding ligation
21. Acute gastrointestinal bleeding from portal hypertensive gastropathy: Prevalence and clinical features
22. Portal hypertension: Diagnosis and treatment
23. The management of bleeding due to portal hypertension: Part 1. The management of acute bleeding episodes
24. A technique of sclerotherapy
25. The rebleeding course and long-term outcome of esophageal variceal hemorrhage after ligation: Comparison with sclerotherapy
26. Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: Influence on gastropathy, gastric varices and variceal recurrence
27. A prospective randomized trial of sclerotherapy versus ligation in the elective treatment of bleeding esophageal varices
28. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices
29. Randomised trial of variceal banding ligation versus injection sclerotherapy for bleeding oesophageal varices
30. Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices
31. A prospective randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices
32. Comparison of endoscopic variceal injection sclerotherapy and ligation for the treatment of esophageal variceal hemorrhage: A prospective randomized trial
33. Emergency banding ligation versus sclerotherapy for the control of active bleeding from esophageal varices
34. Endoscopic sclerotherapy versus variceal ligation in the long-term management of patients with cirrhosis after variceal bleeding. A prospective randomized study
35. Prospective multi-center randomized trial comparing banding ligation with sclerotherapy of esophageal varices
36. 'Superglue', the answer to variceal bleeding and fundal varices?
37. Endoscopic ablation with cyanoacrylate glue for isolated gastric variceal bleeding
38. Pulmonary, cerebral and coronary emboli during bucrylate injection of bleeding fundic varices
39. Embolic and septic complications after sclerotherapy of fundic varices with cyanoacrylate
40. Cyanoacrylate vs sodium tetradecyl sulphate for the injection of bleeding varices in patients with hepatocellular carcinoma
41. Six years' experience of oesophageal transection for oesophageal varices using a circular stapling gun
42. Transabdominal suture of bleeding gastro-oesophageal varices in cryptogenic cirrhosis of the liver
43. Randomized comparison of ligation versus ligation plus sclerotherapy in patients with bleeding esophageal varices
44. Endoscopic variceal ligation is superior to combined ligation and sclerotherapy for esophageal varices: A multicenter prospective randomized trial
45. Sclerotherapy plus ligation versus ligation for the treatment of esophageal varices: A prospective randomized study
46. Randomized trial of ligation versus combined ligation and sclerotherapy for bleeding esophageal varices
47. A new 'sandwich' method of combined endoscopic variceal ligation and sclerotherapy versus ligation alone in the treatment of esophageal variceal bleeding: A randomized trial
48. Repeated injection sclerotherapy is preferable to combined therapy with variceal ligation to avoid recurrence of esophageal varices: A prospective randomized trial
49. Evaluation of endoscopic injection sclerotherapy with and without simultaneous ligation for the treatment of esophageal varices
50. Endoscopic variceal ligation versus endoscopic variceal ligation and endoscopic sclerotherapy: A prospective randomized study
51. The additive effect of sclerotherapy to patients receiving repeated endoscopic variceal ligation: A prospective randomized trial
52. Adjuvant sclerotherapy after ligation for the treatment of esophageal varices: A prospective randomized long term study
53. Comparison of endoscopic variceal sclerotherapy with sequential endoscopic band ligation plus low-dose sclerotherapy for secondary prophylaxis of variceal hemorrhage: A prospective randomized study
54. Ligation plus low-volume sclerotherapy for high-risk esophageal varices: Comparison with ligation therapy or sclerotherapy alone
55. Transjugular intrahepatic portosystemic shunt compared with endoscopic treatment for prevention of variceal rebleeding: A meta-analysis
56. Multicenter investigation of the role of transjugular intrahepatic portosystemic shunt in management of portal hypertension
57. Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis. A prospective, randomized trial
58. A systematic appraisal of portacaval H-graft diameters. Clinical and hemodynamic perspective
59. Liver transplantation in the management of bleeding oesophageal varices